[Diagnostic and therapeutic recommendations for sexually transmitted diseases: Genital herpes].
Recommandations diagnostiques et thérapeutiques pour les maladies sexuellement transmissibles : herpès génital au cours de la grossesse.
Acyclovir
/ administration & dosage
Antiviral Agents
/ administration & dosage
Dose-Response Relationship, Drug
Female
Herpes Genitalis
/ drug therapy
Humans
Infectious Disease Transmission, Vertical
/ prevention & control
Pregnancy
Pregnancy Complications, Infectious
/ drug therapy
Valacyclovir
/ administration & dosage
Aciclovir
Femme enceinte
Genital herpes
Grossesse
HSV
Herpès génital
Pregnancy
Valaciclovir
Journal
Annales de dermatologie et de venereologie
ISSN: 0151-9638
Titre abrégé: Ann Dermatol Venereol
Pays: France
ID NLM: 7702013
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
28
11
2017
accepted:
13
07
2018
pubmed:
28
10
2018
medline:
31
7
2019
entrez:
28
10
2018
Statut:
ppublish
Résumé
TREATMENT OF THE INITIAL INFECTION OR FIRST CLINICAL EPISODE OF GENITAL HERPES: An initial infection or first clinical episode of genital herpes is treated with oral aciclovir 200mg×5/d for 5 to 10 days depending on clinical status. The recommended dosage for valaciclovir is 1g×2/d and treatment duration is identical to that for aciclovir. TREATMENT OF HERPES RECURRING DURING PREGNANCY: There are no studies of the efficacy of antiviral therapy on the symptoms of genital recurring during pregnancy. However, initial anti-viral treatment using aciclovir or valaciclovir may be given where warranted by symptoms (i.e. duration and severity of symptoms). Valaciclovir may be used instead (equivalent efficacy but better safety data for aciclovir). Valaciclovir may be given at a dosage of 1×500mg b.i.d. p.o. for 5 days. PROPHYLACTIC ANTI-VIRAL TREATMENT DURING PREGNANCY: In female patients presenting an initial infection or infection recurring during pregnancy, although there is no demonstrated benefit for prophylactic treatment in reducing the risk of neonatal herpes, anti-viral prophylaxis is recommended after 36 WA (weeks' amenorrhoea) to limit the need for Caesarean section due to herpetic lesions. The recommended antivirals are aciclovir at a dosage of 400mg t.i.d p.o. or valaciclovir at a dosage of 500mg b.i.d. p.o. until delivery.
Identifiants
pubmed: 30366717
pii: S0151-9638(18)30717-8
doi: 10.1016/j.annder.2018.07.029
pii:
doi:
Substances chimiques
Antiviral Agents
0
Valacyclovir
MZ1IW7Q79D
Acyclovir
X4HES1O11F
Types de publication
Journal Article
Review
Langues
fre
Pagination
31-36Informations de copyright
Copyright © 2018 Elsevier Masson SAS. All rights reserved.